GlassScriptPhysician profile
Michael S Agus
NPI 1952382301
$25,039.92
in general payments reported to CMS, 2019-2025
3 companies · $9,463 in 2025
The $9,463 reported for 2025 was more than what 98% of Pediatric Critical Care Medicine providers received nationally (typical 2025 total: $71.68).
See the full distribution for Pediatric Critical Care Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $3,000 · 2023: $4,901 · 2024: $7,676 · 2025: $9,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $2,585 · Food and Beverage: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,750.00 |
| Travel and Lodging | $2,585.05 |
| Food and Beverage | $704.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $22,039.92 | 2023-2025 | |
| Roche Diagnostics International LTD | $3,000.00 | 2020 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Agus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.